Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research
ID: 360574Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360574
Timeline
    Description

    The National Institutes of Health (NIH) is inviting research applications for the Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research, aimed at advancing the understanding of mental disorders through innovative research. The primary objectives include enhancing basic brain and behavior research, integrating clinical neuroscience research on severe mental illnesses, and exploring neurobehavioral developmental mechanisms of psychopathology from childhood to adolescence. This grant opportunity, which has an award ceiling of $2 million, encourages collaborative research teams with a strong synergy in neuroscience to develop impactful project plans, with applications expected to be solicited in the future. For further inquiries, interested parties can contact Dr. Suzanne T. Garcia at suzanne.garcia@nih.gov or by phone at 301-827-1366.

    Point(s) of Contact
    Suzanne T. Garcia, Ph.D.
    (301) 827-1366
    suzanne.garcia@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed) to support innovative and exploratory research projects in neuroscience. This grant program is designed for early-stage projects that align with the missions of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH), focusing on studies that assess the feasibility of novel investigations with the potential for significant breakthroughs in neuroscience. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and foreign entities, with funding available up to $275,000 over two years. The application period opens on January 16, 2025, with anticipated awards by July 2025; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)," aimed at advancing research on high-confidence risk factors associated with complex brain disorders. This grant encourages studies that focus on the intracellular, transcellular, and circuit substrates of neural function, allowing for both hypothesis-generating and hypothesis-testing research designs, while discouraging attempts to model the disorders themselves. The initiative is crucial for enhancing understanding of the biological processes impacted by these disorders, ultimately facilitating therapeutic target identification and enriching data resources. Applications are due by September 7, 2026, with no budget cap, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)" aimed at encouraging research into high-confidence risk factors associated with complex brain disorders such as schizophrenia, bipolar disorder, and major depression. This initiative supports exploratory developmental research (R21) to identify molecular, cellular, and circuit mechanisms involved in these disorders, utilizing diverse experimental paradigms without the necessity for prior feasibility data. The funding amount is capped at $275,000 over two years, with a maximum of $200,000 per year, and eligible applicants include a wide range of educational institutions, nonprofits, and for-profit organizations. Interested parties can find more information and application details at the NIH website, with the application deadline set for September 7, 2026.
    NIMH Mentoring Networks for Mental Health Research Education
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIMH Mentoring Networks for Mental Health Research Education" aimed at enhancing the training of a skilled workforce in biomedical, behavioral, and clinical research. This initiative seeks to support innovative educational activities focused on developing national or regional mentoring networks that foster professional development and career trajectories towards independent mental health research, significantly expanding upon existing mentoring and educational collaborations. The grant has an award ceiling of $200,000, with applications not currently being solicited; however, potential applicants are encouraged to prepare strong proposals in advance of the estimated synopsis close date on May 25, 2026. For further inquiries, interested parties may contact Belinda Sims, Ph.D., at belinda.sims@nih.gov or by phone at 301-435-7155.
    Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the funding opportunity titled "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)," aimed at advancing research on the biological mechanisms underlying complex brain disorders such as schizophrenia, bipolar disorder, and autism. This initiative encourages studies that explore high-confidence risk factors associated with these disorders, focusing on intracellular, transcellular, and circuit mechanisms, while emphasizing the importance of disseminating findings to enhance data resources and therapeutic target identification. Eligible applicants include a wide range of institutions, including historically black colleges, tribal colleges, and various nonprofit organizations, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and detailed information can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-024.html.
    Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV." This initiative aims to support research that identifies modifiable targets and mechanisms to alleviate central nervous system (CNS) complications in individuals living with HIV, leveraging patient-derived data and innovative model platforms. The program emphasizes the importance of understanding the multifactorial nature of CNS dysfunction and seeks to accelerate the development of effective interventions through clinical studies or pre-clinical models. The estimated total funding for this program is $3 million, with approximately six awards expected. Interested applicants, particularly those with expertise in systems biology and translational neurobiology, should prepare for the upcoming Notice of Funding Opportunity (NOFO), with applications anticipated to open in September 2025. For further inquiries, potential applicants can contact Vasudev R Rao at vasudev.rao@nih.gov or by phone at 301-825-3259.
    Discovery of in vivo Chemical Probes for the Nervous System
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the discovery of in vivo chemical probes for the nervous system, specifically targeting novel brain mechanisms. This initiative, led by the National Institute on Aging (NIA) in collaboration with the National Eye Institute (NEI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), seeks applicants who possess validated starting compounds for chemical optimization and bioassays to explore new analog compounds. The focus will be on developing small molecules that can enhance understanding of biological processes relevant to brain diseases, with an emphasis on innovative biological targets. Interested applicants can reach out to Dr. Paul G. Grothaus at grothausp@mail.nih.gov or call 240-688-6634 for further information, with the estimated synopsis posting date set for February 26, 2026, and a projected award date of April 5, 2027.
    NIH Blueprint for Neuroscience: Coordination Center for Interoception Research (BPCCIR) (U24, Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of the NIH Blueprint for Neuroscience Research Coordination Center for Interoception Research (BPCCIR) through a cooperative agreement (U24), with an estimated total program funding of $700,000. The primary objectives of this initiative include fostering a multidisciplinary team of interoception researchers, developing digital communication platforms for collaboration, organizing annual scientific meetings, and identifying challenges and opportunities in interoception research to enhance population health. This research is crucial for understanding internal bodily signals and their implications for health, particularly in relation to chronic diseases and mental health disorders. Interested applicants, including small businesses and other eligible entities, should note that the estimated synopsis close date is November 10, 2025, with an anticipated award date of July 1, 2026. For further inquiries, contact Wen Chen at 301-451-3989 or via email at chenw@mail.nih.gov.
    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)." This grant aims to support innovative research utilizing invasive neural recording methods to explore the neural circuitry associated with mental health disorders, focusing on high-risk applications that address significant gaps in knowledge regarding complex moods and cognitive behaviors. The initiative seeks to bridge basic neuroscience with applied mental health interventions, encouraging diverse research teams to utilize advanced methodologies. The estimated funding amount is capped at $200,000, with applications due by January 7, 2028. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-291.html.
    Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE)," aimed at fostering innovative research in neuroscience through collaborative team science. This initiative encourages applications from transdisciplinary teams of 3-6 principal investigators (PDs/PIs) to tackle complex research questions that can lead to significant advancements in the field, particularly in overcoming barriers and achieving paradigm shifts in neuroscience. The program is designed to support projects that integrate diverse expertise across basic, clinical, and translational neuroscience domains, with the goal of transforming knowledge and practice within a five-year timeframe. Interested applicants are encouraged to prepare for this opportunity, with an estimated synopsis posting date of February 4, 2026, and a closing date for applications expected on June 23, 2026. For further inquiries, potential applicants can contact the NINDS Team Science Group at NINDSteamscience@nih.gov or by phone at 240-328-3447.